Literature DB >> 10376944

B cell-deficient mice have increased susceptibility to HSV-1 encephalomyelitis and mortality.

J L Beland1, R A Sobel, H Adler, N C Del-Pan, I J Rimm.   

Abstract

We studied the susceptibility of B cell-deficient mice to encephalomyelitis following intraperitoneal inoculation of HSV-1. B cell-deficient mice developed striking CNS signs including tail atony, clumsy gait and limb paralysis after HSV-1 infection. In addition, B cell-deficient mice had decreased survival (LD50 = 2.2 x 10(7) PFU) compared to control C57BL/6 mice (LD50 = 2.3 x 10(8) PFU). B cell-deficient mice had encephalomyelitis and detectable virus in the brain 7 days post-infection while C57BL/6 mice did not. Passive transfer of hyperimmune sera protected B cell-deficient mice from death, suggesting a role for antibody in susceptibility to HSV-1 encephalomyelitis.

Entities:  

Mesh:

Year:  1999        PMID: 10376944     DOI: 10.1016/s0165-5728(98)00238-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

Review 1.  Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts.

Authors:  P P Sanna; D R Burton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Prophylactic and therapeutic effects of human immunoglobulin on the pathobiology of HSV-1 infection, latency, and reactivation in mice.

Authors:  Sarat K Dalai; Lesley Pesnicak; Georgina F Miller; Stephen E Straus
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

3.  p53 Is a Host Cell Regulator during Herpes Simplex Encephalitis.

Authors:  Yuhei Maruzuru; Naoto Koyanagi; Naoki Takemura; Satoshi Uematsu; Daisuke Matsubara; Yutaka Suzuki; Jun Arii; Akihisa Kato; Yasushi Kawaguchi
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

4.  Common variable immunodeficiency presenting as herpes simplex virus encephalitis.

Authors:  Larry Borish; Andrew G Ayars; Charles H Kirkpatrick
Journal:  J Allergy Clin Immunol       Date:  2010-12-16       Impact factor: 10.793

5.  The Role of Plasmacytoid Dendritic Cells in Innate and Adaptive Immune Responses against Alpha Herpes Virus Infections.

Authors:  Philipp Schuster; Jan Bernardin Boscheinen; Karin Tennert; Barbara Schmidt
Journal:  Adv Virol       Date:  2011-03-31

6.  HSV-1 0∆NLS vaccine elicits a robust B lymphocyte response and preserves vision without HSV-1 glycoprotein M or thymidine kinase recognition.

Authors:  Grzegorz B Gmyrek; Amanda N Berube; Virginie H Sjoelund; Daniel J J Carr
Journal:  Sci Rep       Date:  2022-09-23       Impact factor: 4.996

7.  Genome-wide mouse mutagenesis reveals CD45-mediated T cell function as critical in protective immunity to HSV-1.

Authors:  Grégory Caignard; Gabriel A Leiva-Torres; Michael Leney-Greene; Benoit Charbonneau; Anne Dumaine; Nassima Fodil-Cornu; Michal Pyzik; Pablo Cingolani; Jeremy Schwartzentruber; Jeremy Dupaul-Chicoine; Huaijian Guo; Maya Saleh; André Veillette; Marc Lathrop; Mathieu Blanchette; Jacek Majewski; Angela Pearson; Silvia M Vidal
Journal:  PLoS Pathog       Date:  2013-09-12       Impact factor: 6.823

8.  Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of Neonates To Prevent HSV Neurological Disease.

Authors:  Yike Jiang; Chaya D Patel; Richard Manivanh; Brian North; Iara M Backes; David A Posner; Francesca Gilli; Andrew R Pachner; Lananh N Nguyen; David A Leib
Journal:  mBio       Date:  2017-07-05       Impact factor: 7.867

Review 9.  Insights into the pathogenesis of herpes simplex encephalitis from mouse models.

Authors:  Mathieu Mancini; Silvia M Vidal
Journal:  Mamm Genome       Date:  2018-08-23       Impact factor: 2.957

Review 10.  Local Immune Control of Latent Herpes Simplex Virus Type 1 in Ganglia of Mice and Man.

Authors:  Anthony J St Leger; David M Koelle; Paul R Kinchington; Georges Michel G M Verjans
Journal:  Front Immunol       Date:  2021-09-15       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.